Tonix Pharmaceuticals Holding (TNXP) Amortizatization of Intangibles (2016 - 2025)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Amortizatization of Intangibles came in at $65000.0 in Q1 2025, down 78.48% year-on-year from $302000.0 in Q1 2024, and down 67.5% quarter-over-quarter from $200000.0 in Q4 2024.
Tonix Pharmaceuticals Holding (TNXP) Amortizatization of Intangibles (2016 - 2025) Analysis & Trends
Tonix Pharmaceuticals Holding's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $65000.0 for Q1 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 78.48% year-over-year to $65000.0 in Q1 2025; TTM through Dec 2025 was $65000.0, a 92.26% decrease from a year earlier, with the FY2025 full-year figure at $65000.0, down 92.26% from the prior year.
- Amortizatization of Intangibles retreated to $65000.0 in Q1 2025 per TNXP's latest filing, from $200000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $302000.0 in Q1 2024 and bottomed at $65000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 209,000.00 |
| Sep 30, 2024 | 209,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | 302,000.00 |
| Mar 31, 2024 | 302,000.00 |
| Sep 30, 2016 | 16,000.00 |
| Sep 30, 2016 | 16,000.00 |